[Chemistry and biochemistry of vitamin K]. 1958

G Scheuerbrandt

UI MeSH Term Description Entries
D009285 Naphthoquinones Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups. Naphthalenediones,Naphthazarins,Naphthoquinone
D006494 Heparin Antagonists Coagulant substances inhibiting the anticoagulant action of heparin. Antagonists, Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000933 Antifibrinolytic Agents Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. Antifibrinolysin,Antifibrinolysins,Antifibrinolytic,Antifibrinolytic Agent,Antiplasmin,Antiplasmins,Antifibrinolytics,Plasmin Inhibitor,Plasmin Inhibitors,Agent, Antifibrinolytic,Agents, Antifibrinolytic,Inhibitor, Plasmin,Inhibitors, Plasmin
D012176 Retinoids A group of tetraterpenes, with four terpene units joined head-to-tail. Biologically active members of this class are used clinically in the treatment of severe cystic ACNE; PSORIASIS; and other disorders of keratinization. Retinoid
D014812 Vitamin K A lipid cofactor that is required for normal blood clotting. Several forms of vitamin K have been identified: VITAMIN K 1 (phytomenadione) derived from plants, VITAMIN K 2 (menaquinone) from bacteria, and synthetic naphthoquinone provitamins, VITAMIN K 3 (menadione). Vitamin K 3 provitamins, after being alkylated in vivo, exhibit the antifibrinolytic activity of vitamin K. Green leafy vegetables, liver, cheese, butter, and egg yolk are good sources of vitamin K.

Related Publications

G Scheuerbrandt
August 2005, Biochemical Society transactions,
G Scheuerbrandt
April 1985, Nederlands tijdschrift voor geneeskunde,
G Scheuerbrandt
September 1963, Schweizerische medizinische Wochenschrift,
G Scheuerbrandt
September 1998, Investigacion clinica,
G Scheuerbrandt
June 1949, Produits pharmaceutiques,
G Scheuerbrandt
January 1981, Progress in clinical and biological research,
G Scheuerbrandt
January 1946, Journal of the Mount Sinai Hospital, New York,
G Scheuerbrandt
January 1987, Advances in experimental medicine and biology,
G Scheuerbrandt
December 1973, Science (New York, N.Y.),
Copied contents to your clipboard!